Now showing items 1-2 of 2

    • Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer 

      D'Andrea, D.; Black, P. C.; Zargar, H.; Zargar-Shoshtari, K.; Soria, F.; Fairey, A. S.; Mertens, L. S.; Dinney, C. P.; Mir, M. C.; Krabbe, L. M.; Cookson, M. S.; Jacobsen, N. E.; Montgomery, J. S.; Vasdev, N.; Yu, E. Y.; Xylinas, E.; Campain, N. J.; Kassouf, W.; Dall'Era, M. A.; Seah, J. A.; Ercole, C. E.; Horenblas, S.; Sridhar, S. S.; McGrath, J. S.; Aning, J.; Wright, J. L.; Thorpe, A. C.; Morgan, T. M.; Holzbeierlein, J. M.; Bivalacqua, T. J.; North, S.; Barocas, D. A.; Lotan, Y.; Grivas, P.; Stephenson, A. J.; Shah, J. B.; van Rhijn, B. W.; Daneshmand, S.; Spiess, P. E.; Shariat, S. F. (Springer, 2021-08-09)
      PURPOSE: To assess the association of patient age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (MIBC). MATERIALS AND METHODS: We analyzed data from 1105 patients with MIBC. ...
    • Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer 

      D'Andrea, D.; Black, P. C.; Zargar, H.; Dinney, C. P.; Soria, F.; Cookson, M. S.; Montgomery, J. S.; Kassouf, W.; Dall'Era, M. A.; Sridhar, S. S.; McGrath, J. S.; Wright, J. L.; Thorpe, A. C.; Holzbeierlein, J. M.; Carrión, D. M.; Di Trapani, E.; Bivalacqua, T. J.; North, S.; Barocas, D. A.; Lotan, Y.; Grivas, P.; Stephenson, A. J.; van Rhijn, B. W.; Daneshmand, S.; Spiess, P. E.; Shariat, S. F. (Lippincott, Williams & Wilkins, 2021-08-27)
      PURPOSE: We investigated the pathological response rates and survival associated with 3 vs 4 cycles of cisplatin-based neoadjuvant chemotherapy (NAC) in patients with cT2-4N0M0 muscle invasive bladder cancer. MATERIALS AND ...